Who are Transdermal glyceryl trinitrate patch's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Verquvo, Adempas, Inomax, Nitroglycerin, Nitroprusside, Sodium, Monoket Pill.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/transdermal-glyceryl-trinitrate-patch.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Transdermal glyceryl trinitrate patch — Competitive Intelligence Brief

Transdermal glyceryl trinitrate patch (Transdermal glyceryl trinitrate patch) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Nitrate. Area: Cardiovascular.

phase 3 Nitrate Guanylate cyclase Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Transdermal glyceryl trinitrate patch (Transdermal glyceryl trinitrate patch) — University of Nottingham. Transdermal glyceryl trinitrate patch works by releasing nitric oxide, which causes vasodilation and reduces blood pressure.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Transdermal glyceryl trinitrate patch TARGET	Transdermal glyceryl trinitrate patch	University of Nottingham	phase 3	Nitrate	Guanylate cyclase
Verquvo	VERICIGUAT	Merck & Co.	marketed	Soluble Guanylate Cyclase Stimulator [EPC]	Guanylate cyclase soluble subunit beta-1	2021-01-01
Adempas	RIOCIGUAT	Bayer	marketed	Soluble Guanylate Cyclase Stimulator [EPC]	Guanylate cyclase soluble subunit beta-1	2013-01-01
Inomax	NITRIC OXIDE	Vero Biotech Inc	marketed	Standardized Chemical Allergen [EPC]	Soluble guanylate cyclase	1999-01-01
Nitroglycerin	glyceryl trinitrate	Fougera	marketed	Nitrate Vasodilator [EPC]	guanylate cyclase	1981-01-01
Nitroprusside, Sodium	Nitroprusside, Sodium	Cristália Produtos Químicos Farmacêuticos Ltda.	marketed	Nitrovasodilator	Soluble guanylate cyclase (via nitric oxide)
Monoket Pill	Monoket Pill	Ohio State University	marketed	Nitrate vasodilator	Soluble guanylate cyclase (via nitric oxide)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2029-03-12 — Nitroglycerin · 7872049 · US
2032-03-11 — Nitroglycerin · 9101592 · US

Sponsor landscape (Nitrate class)

University of Nottingham · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Transdermal glyceryl trinitrate patch — Competitive Intelligence Brief. https://druglandscape.com/ci/transdermal-glyceryl-trinitrate-patch. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab